No abstract available.
Uterine Prolapse*

No abstract available.
Female ; Pregnancy ; Pregnancy, Ectopic*

No abstract available.

No abstract available.
Cystic Adenomatoid Malformation of Lung, Congenital* ; Diagnosis*

No abstract available.

No abstract available.
Trisomy*

Background: With increasing economic evaluation studies on the treatment of or screening tools for liver diseases that cause hepatocellular carcinoma (HCC), interest in the analysis of the medical utilization and costs of HCC treatment is increasing. Therefore, we aimed to estimate the medical utilization and costs of HCC patients, and calculate the cost of main procedures for HCC treatment, including liver transplant (LT), hepatic resection (HR), radiofrequency ablation (RFA), and transarterial chemoembolization (TACE). Methods: We analyzed claim data from January to December 2018 from the Health Insurance and Review and Assessment Service–National Patient Sample (HIRA-NPS-2018) dataset, including data of patients diagnosed with HCC (Korean Standard Classification of Diseases code C22.0) who had at least one inpatient claim for HCC. Results: A total of 715 HCC patients were identified. In 2018, the yearly average medical cost per HCC patient was ₩18,460K (thousand), of which ₩14,870K was attributed to HCC. Among the total medical costs of HCC patients, the inpatient cost accounted for the largest portion of both the total medical and HCC-related costs. The major procedures of HCC treatment occurred most frequently in the order of TACE, RFA, HR, and LT. The average medical cost per treatment episode was the highest for LT (₩87,280K), followed by HR (₩10,026K), TACE (₩4,047K), and RFA (₩2,927K). Conclusion By identifying the medical costs of HCC patients and the costs of the main procedures of HCC treatment, our results provide basic information that could be utilized for cost estimation in liver disease-related economic evaluation studies.

Background: With increasing economic evaluation studies on the treatment of or screening tools for liver diseases that cause hepatocellular carcinoma (HCC), interest in the analysis of the medical utilization and costs of HCC treatment is increasing. Therefore, we aimed to estimate the medical utilization and costs of HCC patients, and calculate the cost of main procedures for HCC treatment, including liver transplant (LT), hepatic resection (HR), radiofrequency ablation (RFA), and transarterial chemoembolization (TACE). Methods: We analyzed claim data from January to December 2018 from the Health Insurance and Review and Assessment Service–National Patient Sample (HIRA-NPS-2018) dataset, including data of patients diagnosed with HCC (Korean Standard Classification of Diseases code C22.0) who had at least one inpatient claim for HCC. Results: A total of 715 HCC patients were identified. In 2018, the yearly average medical cost per HCC patient was ₩18,460K (thousand), of which ₩14,870K was attributed to HCC. Among the total medical costs of HCC patients, the inpatient cost accounted for the largest portion of both the total medical and HCC-related costs. The major procedures of HCC treatment occurred most frequently in the order of TACE, RFA, HR, and LT. The average medical cost per treatment episode was the highest for LT (₩87,280K), followed by HR (₩10,026K), TACE (₩4,047K), and RFA (₩2,927K). Conclusion By identifying the medical costs of HCC patients and the costs of the main procedures of HCC treatment, our results provide basic information that could be utilized for cost estimation in liver disease-related economic evaluation studies.

BACKGROUND AND OBJECTIVES: Arrhythmia is known to be a major cause of death in acute myocardial infarction (AMI). Reperfusion arrhythmias (RA) may also occur during angioplasty or thrombolysis. As yet, the clinical significances of RA and angiographic characteristics of the patients who develop RA during primary angioplasty and stenting are not clearly defined. METHODS: The study group consisted of 60 patients treated with primary angioplasty or stenting for AMI (angioplasty 13, stenting 47 patients). The patients were classified into 2 groups according to RA [RA (-) N=36/RA(+) N=24]: demographic and angiographic characteristics including time to reperfusion and incidence of pre-infarct angina were analyzed. RESULTS: The RA occurred in 40% of patients undergoing primary angioplasty or stenting (24/60 patients). The minor arrhythmias were more common after reperfusion (transient bradycardia 14, accelerated idioventricular rhythm 11, premature ventricular contraction 4 cases): major arrhythmias were uncommon (ventricular tachycardia/fibrillation 5, asystole 1 case). In the two groups, baseline clinical characteristics were similar except for pain to reperfusion time [RA (-): RA (+)=490.8+/-291.7: 252.9+/-109.2 minutes, P=0.001]. There was a trend toward a greater incidence of RA in the right coronary infarct-related artery [RA (-): RA (+)=16.7: 41.7%, P=NS]. The RA occurred in totally occluded artery (TIMI 0) with a giant thrombus and first ballooning in 19/24 patients (79.2%). The RA disappeared with conservative managements including pacemaker insertion and cardiopulmonary resuscitation and there were no differences in major adverse cardiac events in the two groups during follow-up. CONCLUSIONS: These findings suggest that the RA are frequent events during primary angioplasty but unrelated to clinical and angiographic characteristics except for reperfusion time and do not influence short-term prognosis in AMI.
Accelerated Idioventricular Rhythm ; Angioplasty* ; Arrhythmias, Cardiac* ; Arteries ; Bradycardia ; Cardiopulmonary Resuscitation ; Cause of Death ; Follow-Up Studies ; Heart Arrest ; Humans ; Incidence ; Myocardial Infarction* ; Prognosis ; Prospective Studies* ; Reperfusion* ; Stents ; Thrombosis ; Ventricular Premature Complexes

PURPOSE: This study was designed to determine the epidemiological and clinical characteristics of patients suspected or confirmed with to be infected by the pandemic 2009 H1N1 virus in one emergency medical center. METHODS: This was a prospective observational study. It was conducted between September 1 and November 30, 2009 in one tertiary academic emergency department. We recorded clinical and epidemiologic features of patients infected by the pandemic 2009 H1N1 virus. A follow-up telephone survey was done to determine the final outcome of infection. This survey was conducted by ED personnel 1 week after the initial visit. Multivariate logistic regression analysis was done for the association between disposition or H1N1 influenza diagnosis and potential predictors. RESULTS: During the study period, a total 5,317 patients visited the influenza clinical center of our emergency department. Among them, 1,472 patients (27.7%) were confirmed as influenza A by RT-PCR methods. Among RT-PCR positive patients, 90 (1.7%) were admitted to the ward and 7 to the intensive care unit. Five patients needed mechanical ventilation and one patient was diagnosed as ARDS; the ARDS patient fully recovered. There was no mortality caused by H1N1. The median age of confirmed patients was 9 years (range, 1 month~81 years); 825 patients (56.1%) were male. Incident rates for common symptoms were: fever (92.8%), cough (84.1%), and rhinorrhea (44.0%) by. A total of 40.3% (593/1472) patients were of pre-school age (range, 1 month~7 years, median 4 years). In young patients, clinical characteristics were similar to those of adults. Male, young age, contact history, lack of seasonal influenza vaccination, chronic renal failure, malignancy, and pregnancy were significantly associated with a confirmed diagnosis of H1N1. Hypertension, chronic renal failure, malignancy, neurologic disease, dyspnea, seizure, vomiting, and chest pain were also associated with risk of admission to the hospital. CONCLUSION: Surveillance of H1N1 virus cases shows that the majority of those infected have a mild illness. The 2009 H1N1 virus is common among individuals of pre-school age. Few H1N1-related severe illnesses occur in young individuals.
Adult ; Chest Pain ; Cough ; Disease Outbreaks ; Dyspnea ; Emergencies ; Fever ; Follow-Up Studies ; Humans ; Hypertension ; Influenza A Virus, H1N1 Subtype ; Influenza, Human ; Intensive Care Units ; Kidney Failure, Chronic ; Logistic Models ; Male ; Pandemics ; Pregnancy ; Prospective Studies ; Respiration, Artificial ; Seasons ; Seizures ; Telephone ; Vaccination ; Vomiting